Cancer Engineering Overview

Principles

Definition

Cancer engineering is an interdisciplinary research field that applies engineering principles, quantitative methodologies, and systems-level thinking to understand, model, and manipulate the complex biological and physical processes involved in cancer. This approach investigates tumor initiation, progression, and metastasis, driving the development of novel diagnostic technologies, predictive tools, and advanced therapeutic strategies.

Ontological type

Core Methods

Therapeutic Strategies

Tumor Microenvironment

Key developments

Key Figures

3D Tumor Engineering era

Rakesh K. Jain [1] was active in this era at Harvard University [3] and the Massachusetts Institute of Technology [4]. His key contribution is the multistage nanoparticle delivery system for deep penetration into tumor tissue [5], a development that addressed intratumoral transport barriers and underpinned the era's focus on engineering nanoparticle transport in 3D tumor models. Triantafyllos Stylianopoulos [2] likewise operated across Harvard University [3] and the Massachusetts Institute of Technology [4] in this period. The paper Multistage nanoparticle delivery system for deep penetration into tumor tissue [5] embodies Stylianopoulos's contributions, illustrating how multistage, programmable nanocarriers can overcome transport barriers in 3D tumor ecosystems.

Stimuli-Responsive Nanomedicine era

Jun Wang[1], affiliated with Huazhong Agricultural University[3] and the University of Science and Technology of China[4], epitomizes the Stimuli-Responsive Nanomedicine era. His key contributions in this era are exemplified by Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy[6], which demonstrate how engineered clustering and payload release can overcome tumor penetration barriers and enhance therapeutic outcomes. Jin-Zhi Du[2], with ties to the University of Science and Technology of China[4] and Emory University[5], exemplifies the cross-institutional collaboration characteristic of this era. Du[2] co-authored Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy[6], illustrating how collaborative, multi-institutional teams advanced the design of responsive nanomedicines that enable deeper penetration and site-specific activation.

Membrane-Coated Nanomedicine era

Liangfang Zhang's group at UC San Diego emerged as a central authority in membrane-coated nanoparticles, demonstrating red blood cell and cancer cell membrane cloaks that suppress immune clearance and enhance tumor homing. Renfeng Fang, a frequent collaborator, helped establish RBC membrane cloaks and showed how native stealth translates into prolonged circulation and increased tumor accumulation. Diego Dehaini and Wei Gao extended the approach to platelet and other cell membranes, enabling programmable surface phenotypes and more selective tumor vasculature targeting while preserving immune evasion. Across this era, these researchers fused membrane cloaks with modular, stimuli-responsive designs and high-capacity carriers such as metal-organic frameworks, enabling smarter cargo loading and controllable intratumoral release for cancer nanotherapies.